FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology, and concerns the use of rapamycin derivatives. For this, an effective amount of 40-O-(2-hydroxyethyl)-rapamycin is administered.
EFFECT: effective treatment of developed dense tumors due to expressed antiproliferative properties of this drug.
5 cl
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION OF RAPAMYCIN DERIVATIVE | 2013 |
|
RU2665138C2 |
| USE OF RAPAMYCIN DERIVATIVE | 2011 |
|
RU2483727C1 |
| INHIBITION OR PREVENTION OF DISTURBED ANGIOGENIC REGULATION WITH USING RAPAMYCIN DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING RAPAMYCIN DERIVATIVE | 2006 |
|
RU2445093C2 |
| CANCER MEDICAL TREATMENT | 2005 |
|
RU2325906C2 |
| COMBINATION AND METHOD FOR PROPHYLAXIS OF BREAST CANCER | 2002 |
|
RU2322981C2 |
| BIOMARKER | 2005 |
|
RU2385944C2 |
| BIOMARKERS | 2005 |
|
RU2429297C2 |
| STENTS WITH COATING CONTAINING N-{5-[4-(4-METHYLPIPERAZINOMETHYL)BENZOYL-AMIDO]-2-METHYLPHENYL}-4-(3-PYRIDYL)-2-PYRIMIDINAMIN | 2003 |
|
RU2341266C2 |
| NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTI-CANCER AGENT | 2008 |
|
RU2483714C2 |
| NANOPARTICLE, CONTAINING RAPAMYCIN AND ALBUMIN AS ANTICANCER AGENT | 2013 |
|
RU2678448C2 |
